Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Nausea in Gastroparesis (APRON)
NCT01149369Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Apr 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in gastroparesis, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Apr 2013; status: completed.
02
Drugs
aprepitant
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT01149369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149369.